文献速递肥胖与代谢综合征

多组分干预对超重或肥胖儿童肝脏脂肪变性的影响部分由腹壁肌间脂肪组织减少介导:EFIGRO项目

Effect of a Multicomponent Intervention on Hepatic Steatosis Is Partially Mediated by the Reduction of Intermuscular Abdominal Adipose Tissue in Children With Overweight or Obesity: The EFIGRO Project.
PubMed 文献 · Diabetes Care · 2022-01-01

本研究将116名超重或肥胖儿童分配至22周家庭生活方式与心理教育干预组(对照组,n=57)或相同干预加监督运动组(运动组,n=59)。MRI显示腹壁肌间脂肪组织(IMAAT)变化解释了肝脏脂肪变性改善的20.7%(P<0.05)。仅IMAAT显著减少的应答者肝脏脂肪变性改善(组内-20%,P=0.005),且独立于腹部脂肪减少。

要点

  • IMAAT变化解释了肝脏脂肪变性改善的20.7%(P<0.05)。
  • 仅IMAAT应答者肝脏脂肪变性改善(组内-20%,P=0.005),非应答者-1.5%(P=0.803)。
  • 组间比较IMAAT应答者较非应答者肝脏脂肪减少更明显(18.3% vs 0.6%,P=0.018)。

核心结论

  • 多组分干预后IMAAT减少在超重或肥胖儿童肝脏脂肪变性改善中起重要作用,仅IMAAT显著减少的儿童肝脏脂肪百分比降低且独立于腹部脂肪减少,腹部肌肉脂肪浸润可能是儿童MAFLD的治疗靶点。

研究设计与样本

  • 将116名超重或肥胖儿童分配至22周家庭生活方式与心理教育干预组(对照组,n=57)或相同干预加监督运动组(运动组,n=59)。

主要发现

  • IMAAT变化解释了肝脏脂肪变性改善的20.7%(P<0.05)。
  • 仅IMAAT显著减少的应答者肝脏脂肪变性改善(组内-20%,P=0.005),非应答者-1.5%(P=0.803)。
  • 组间分析显示IMAAT应答者较非应答者肝脏脂肪减少更明显(18.3% vs 0.6%,P=0.018),且独立于整体腹部脂肪减少。

关键数值与推荐

  • IMAAT应答者组内肝脏脂肪变化-20%(P=0.005),非应答者-1.5%(P=0.803)。
  • 组间肝脏脂肪减少:IMAAT应答者18.3% vs 非应答者0.6%(P=0.018)。
  • IMAAT变化对肝脏脂肪变性改善的介导比例为20.7%(P<0.05)。

临床怎么用

  • 作者认为腹部肌肉脂肪浸润可能是儿童MAFLD的治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In adults, there is evidence that improvement of metabolic-associated fatty liver disease (MAFLD) depends on the reduction of myosteatosis. In children, in whom the prevalence of MAFLD is alarming, this muscle-liver crosstalk has not been tested. Therefore, we aimed to explore whether the effects of a multicomponent intervention on hepatic fat is mediated by changes in intermuscular abdominal adipose tissue (IMAAT) in children with overweight/obesity. RESEARCH DESIGN AND METHODS: A total of 116 children with overweight/obesity were allocated to a 22-week family-based lifestyle and psychoeducational intervention (control group, n = 57) or the same intervention plus supervised exercise (exercise group, n = 59). Hepatic fat percentage and IMAAT were acquired by MRI at baseline and at the end of the intervention. RESULTS: Changes in IMAAT explained 20.7% of the improvements in hepatic steatosis (P < 0.05). Only children who meaningfully reduced their IMAAT (i.e., responders) had improved hepatic steatosis at the end of the intervention (within-group analysis: responders -20% [P = 0.005] vs. nonresponders -1.5% [P = 0.803]). Between-group analysis showed greater reductions in favor of IMAAT responders compared with nonresponders (18.3% vs. 0.6%, P = 0.018), regardless of overall abdominal fat loss. CONCLUSIONS: The reduction of IMAAT plays a relevant role in the improvement of hepatic steatosis after a multicomponent intervention in children with overweight/obesity. Indeed, only children who achieved a meaningful reduction in IMAAT at the end of the intervention had a reduced percentage of hepatic fat independent of abdominal fat loss. Our findings suggest that abdominal muscle fat infiltration could be a therapeutic target for the treatment of MAFLD in childhood.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Cadenas-Sanchez C, Idoate F, Cabeza R, et al. Effect of a Multicomponent Intervention on Hepatic Steatosis Is Partially Mediated by the Reduction of Intermuscular Abdominal Adipose Tissue in Children With Overweight or Obesity: The EFIGRO Project. Diabetes Care. 2022. PMID: 36044664. doi:10.2337/dc21-2440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。